A highly experienced neurosurgeon, Dr. Borden has developed novel, minimally invasive treatments for spine conditions. Dr. Borden is the primary investigator for several national FDA-IDE studies. His research includes new treatment involving growth factors and stem cell therapies for disc regeneration, as well as new minimally invasive and motion preserving surgeries. Dr. Borden was the Director of the Boston Gamma Knife Center where he developed expertise in tumors involving the optic nerves and chiasm.

While on the faculty at Tufts in Boston, he developed what is now known as the "Borden Classification" of dural arteriovenous malformations or fistulas of the brain and spine. He has leveraged new minimally invasive treatments for brain, cranial nerve, and spinal conditions.

While in Boston, he also developed new surgical treatments for vascular malformations of the brain and spinal cord.


Board Certifications

American Board of Neurological Surgery


Residencies/Internships

Intern in Surgery (1988-1989),
Tufts-New England Medical Center, Boston

Resident in Neurosurgery (1989-1994)
Tufts-New England Medical Center, Boston

Chief Resident in Neurosurgery (1994-1995)
Tufts-New England Medical Center, Boston

Graduate

Doctor of Medicine (1988)
Yale University School of Medicine, Alpha Omega Alpha

Bachelor of Arts (1984)
Amherst College (Neuroscience), Magna Cum Laude


Leadership/Awards/Associations

-James Olds Memorial Neuroscience Award, Amherst College
-Chromosoma Award, Berlin
-Congress of Neurological Surgeons, First Place Vascular Award
-Board of Editors, The Yale Journal of Biology and Medicine
-NASA Astrophysics/Applied Information Science Review Panel
-NASA Science Archives Working Group (SAWG)
-Diplomate, American Board of Neurological Surgery